Johnson & Johnson today announced it has completed its acquisition of Intra-Cellular Therapies, Inc. Intra-Cellular Therapies is now part of Johnson & Johnson and will operate as a business unit ...
Introduction: Non-chemotherapy drug-induced agranulocytosis (NCDIA) is a serious adverse reaction that significantly increases the risk of life-threatening infections. Although the association between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback